Showing results (391-400 of 456) with videos related to
Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Heterocyclic derivatives of 2-(3,5-dimethylphenyl)tryptamine as GnRH receptor antagonistsP Lin, M Parikh, J L Lo, et al.Endocrine|April 27, 2001
Growth hormone secretagogue receptor family members and ligandsR G Smith, R Leonard, A R Bailey, et al.The Journal of Biological Chemistry|March 13, 1999
L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand bindingA Elbrecht, Y Chen, A Adams, et al.Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Synthesis and biological activities of spiroheterocyclic growth hormone secretagoguesM H Chen, P P Pollard, A A Patchett, et al.Journal of Intellectual Disability Research : JIDR|September 25, 2012
Fractional anisotropy distributions in 2- to 6-year-old children with autismC Cascio, M Gribbin, S Gouttard, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Tripeptide growth hormone secretagoguesL Yang, G Morriello, Y Pan, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Acyclic structural variants of growth hormone secretagogue L-692,429P Lin, J M Pisano, W R Schoen, et al.Science (New York, N.Y.)|June 11, 1993
A nonpeptidyl growth hormone secretagogueR G Smith, K Cheng, W R Schoen, et al.Neuroendocrinology|August 26, 1999
Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleusA R Bailey, M Giles, C H Brown, et al.Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transferG Zhou, R Cummings, Y Li, et al.Pageof 46